Englese Thomas 4
4 · AZIYO BIOLOGICS, INC. · Filed Dec 15, 2021
Insider Transaction Report
Form 4
Englese Thomas
Chief Commercial Officer
Transactions
- Purchase
Class A Common Stock
2021-12-14$6.10/sh+4,580$27,938→ 5,088 total
Footnotes (1)
- [F1]Includes 508 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.